Biopreservation Market Size & Share Analysis - Growth Trends & Forecasts (2023–2028)
The Biopreservation Market is projected to experience a Compound Annual Growth Rate (CAGR) of 15.3% during the forecast period. The COVID-19 pandemic significantly impacted this sector due to heightened research and development by pharmaceutical and biotech firms. This surge aimed at vaccine development, necessitating biopreservation methods for storage and shipping, notably for mRNA vaccines like Pfizer-BioNTech, Moderna, and Janssen.
Biopreservation's impact spans public health and socio-economic domains, particularly in cell/tissue preservation for reproductive medicine, organ transplantation, stem cell banking, and gene banking, all garnering global attention.
Market growth is fueled by increased healthcare spending, in-house sample storage in medical facilities, and escalated research investments. Moreover, rising funds directed at biopreservation-based companies, like X-Therma Inc. and Ori Biotech securing substantial investments, are propelling market expansion. Notable collaborations and acquisitions, such as Guy's and St Thomas' fertility preservation service launch, are also driving growth through technological advancements and cost-effective solutions.
However, challenges like high instrument costs, maintenance expenses, and potential tissue injury during preservation pose hurdles to market expansion.
As for market trends, regenerative medicine is anticipated to dominate the industry. These medicines, crucial in repairing, replacing, and regenerating tissues and organs affected by injury, diseases, or aging, are witnessing significant growth. Partnerships worldwide aimed at advancing regenerative medicine, like the Regenerative Medicine Catalyst Project, are anticipated to propel this segment further. The increased demand for regenerative medicine utilizing biopreservation for treating life-threatening diseases like cancer is a key driver for this segment's growth.
Comments
Post a Comment